| 发明名称 | Extended release compositions comprising tolterodine | ||
| 摘要 | The present invention deals with extended release pharmaceutical compositions comprising tolterodine, wherein the composition comprises: a) a drug layer comprising tolterodine tartrate, monosaccharide and/or disaccharide on an inert core; or a drug core comprising tolterodine tartrate, monosaccharide and/or disaccharide; and b) a polymer layer comprising extended release polymer(s). The invention also provides a process for the preparation of the above mentioned composition. | ||
| 申请公布号 | US8871275(B2) | 申请公布日期 | 2014.10.28 |
| 申请号 | US200812672435 | 申请日期 | 2008.08.06 |
| 申请人 | Inventia Healthcare Private Limited | 发明人 | Jaiswal Sunil Beharilal;Shah Ankur Janak |
| 分类号 | A61K9/16;A61K31/137;A61K9/14;A61K9/20;A61K9/22;A61K9/48;A61K9/52;A61K9/54;A61K9/56;A61K9/60;A61K9/62;A61K9/50 | 主分类号 | A61K9/16 |
| 代理机构 | Cook Alex Ltd. | 代理人 | Cook Alex Ltd. |
| 主权项 | 1. An extended release pharmaceutical composition comprising tolterodine and an extended release polymer(s), wherein the composition comprises: a) i) a drug layer comprising tolterodine tartrate and monosaccharide and/or disaccharide on an inert core wherein the drug layer is substantially free of the extended release polymer; or ii) a drug core comprising tolterodine tartrate and monosaccharide and/or disaccharide wherein the drug core is substantially free of the extended release polymer; and b) a polymer layer comprising extended release polymer(s). | ||
| 地址 | IN | ||